Hepatic and cardiovascular safety of acarbose among type 2 diabetes patients with end-stage renal disease: A nationwide population-based longitudinal study-Reference-Cited by-同舟云学术

Hepatic and cardiovascular safety of acarbose among type 2 diabetes patients with end-stage renal disease: A nationwide population-based longitudinal study

Published:2021-02 Issue: Volume:172 Page:108489
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Lin Wei-Hung,Yang Chen-Yi,Kuo Shihchen,Kuo Te-Hui,Roan Jun-Neng,Li Chung-Yi,Wang Ming-Cheng,Ou Huang-Tz

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States;Collins;Am J Kidney Dis,2012

2. United States Renal Data System. 2015 USRDS annual data report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2015.

3. Renal protection in diabetes: role of glycemic control;Fioretto;J Am Soc Nephrol,2006

4. National Kidney F. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis 2012;60:850-886

5. American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes care 2019;42:S13-S28

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced α‐glycosidase inhibition through synergistic interactions: A comprehensive analysis of dihydromyricetin and acarbose in vine tea extracts;International Journal of Food Science & Technology;2024-06-23

2. The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose–response meta-analysis of randomized clinical trials;Frontiers in Nutrition;2023-08-01

3. Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease;World Journal of Diabetes;2023-04-15

4. High-throughput hemodialysis on the clinical efficacy and micro-inflammatory state, calcium and phosphorus metabolism, heart and kidney function in patients with end-stage renal disease;BIO Web of Conferences;2022

5. Flavonoids as Human Intestinal α-Glucosidase Inhibitors;Foods;2021-08-20